Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jan 8, 2007 at 3:43 AM EST

The Biotech Industry: 30 Years of Failure

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology as a business arguably began with the birth of Genentech (DNA) 30…

Douglas A. McIntyre | Jan 5, 2007 at 6:12 PM EST

Cramer’s #3 Speculative Stock for 2007

Tonight Cramer continued his quest of delivering his favorite TOP 3 SPECULATIVE STOCKS FOR 2007. Cramer started off with his…

Douglas A. McIntyre | Jan 5, 2007 at 5:02 AM EST

Bioject’s Needle-Free Delivery Technology Used by NIH

From BioHealth Investor Bioject Medical Technologies Inc (BJCT) announced early Thursday that the National Institutues of Health (NIH) has initiated…

Douglas A. McIntyre | Jan 5, 2007 at 5:01 AM EST

Thursday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INNOVIVE PHARMACEUTL [IVPH.OB] +23.46% XTL BIOPHARMACEUTICA [XTLB] +22.88% STEMCELLS INC [STEM] +16.92% MEMORY PHARMACEUTICA [MEMY] +16.73%…

Douglas A. McIntyre | Jan 5, 2007 at 4:59 AM EST

Stem Cell Stocks Jump on New Congress Promise

From BioHealth Investor by H.S. AyoubBioHealth Investor Stem cell stocks gained big time on Thursday as the new U.S. congress…

Douglas A. McIntyre | Jan 4, 2007 at 1:07 PM EST

The Smart Money Dumps Generic Drugs

Stocks: (PFE)(MRK)(TEVA) Conventional wisdom has been that generic drug companies are going to put Big Pharma out of business. As…

Douglas A. McIntyre | Jan 4, 2007 at 6:04 AM EST

Will Pfizer Cut Its Own Throat? (PFE)

Pfizer is raising prices on its drugs an average of about 5% going into 2007. Lipitor, the world’s top-selling drug,…

Douglas A. McIntyre | Jan 4, 2007 at 4:40 AM EST

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INNCARDIO INC [ICDO.OB] +23.76% CYTOKINETICS [CYTK] +11.50% PIPEX PHARMACEUTICAL [PPXP.OB] +11.30% BIONOVO INC [BNVI.OB] +10.74% MEMORY…

Douglas A. McIntyre | Jan 4, 2007 at 4:39 AM EST

Indian Generic Drug Maker Targets Sad Americans

From BioHealth I read a very well written article penned recently by Nature staff reporter Erika Check for Wired Magazine.…

Douglas A. McIntyre | Jan 3, 2007 at 4:59 AM EST

Vertex Hepititis C Candidate May Be a Success Story

From BioHealth Investor It seems like Vertex Pharmaceuticals (VRTX) is the subject of the majority of my articles (link one,…

Douglas A. McIntyre | Jan 2, 2007 at 10:00 AM EST

Big Pharma Whines About Generics

If you can’t beat them, cry about them. the chairman of Sanofi-Aventis of France recently complained that generic drug companies…

Douglas A. McIntyre | Dec 28, 2006 at 5:12 AM EST

A Reprieve For Boston Scientific (BSX)

Put back the crash carts. Boston Scientific is up and walking. A sharp decline in coated drug stents, brought on…

Douglas A. McIntyre | Dec 27, 2006 at 5:26 AM EST

Tuesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology NEURALSTEM INC [NRLS.OB] +19.05% REPROS THERAPEUTICS [RPRX] +16.52% CYTORI THERAPEUTICS [CYTX] +13.83% ADVENTRX PHARMACTL [ANX] +10.98%…

Douglas A. McIntyre | Dec 27, 2006 at 5:24 AM EST

VIVUS Looking to Profit from Obesity and Sexual Dysfunction

by H.S. AyoubBioHealthInvestor.com Unless you have been under a rock, and not under a bed cover, you have probably heard…

Douglas A. McIntyre | Dec 26, 2006 at 6:07 AM EST

Pfizer Draw Short Interest (PFE)(MRK)

Short interest in Pfizer rose 6.8 million shares to 51.1 million in December. Market fears that generics will eat away…

1 … 386 387 388 389 390 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

The Biotech Industry: 30 Years of Failure

Cramer’s #3 Speculative Stock for 2007

Bioject’s Needle-Free Delivery Technology Used by NIH

Thursday’s Top Biotech and Medical Stocks

Stem Cell Stocks Jump on New Congress Promise

The Smart Money Dumps Generic Drugs

Will Pfizer Cut Its Own Throat? (PFE)

Wednesday’s Top Biotech and Medical Stocks

Indian Generic Drug Maker Targets Sad Americans

Vertex Hepititis C Candidate May Be a Success Story

Big Pharma Whines About Generics

A Reprieve For Boston Scientific (BSX)

Tuesday’s Top Biotech and Medical Stocks

VIVUS Looking to Profit from Obesity and Sexual Dysfunction

Pfizer Draw Short Interest (PFE)(MRK)

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

Health and Healthcare Articles

All Health and Healthcare Articles

The Biotech Industry: 30 Years of Failure

Cramer’s #3 Speculative Stock for 2007

Bioject’s Needle-Free Delivery Technology Used by NIH

Thursday’s Top Biotech and Medical Stocks

Stem Cell Stocks Jump on New Congress Promise

The Smart Money Dumps Generic Drugs

Will Pfizer Cut Its Own Throat? (PFE)

Wednesday’s Top Biotech and Medical Stocks

Indian Generic Drug Maker Targets Sad Americans

Vertex Hepititis C Candidate May Be a Success Story

Big Pharma Whines About Generics

A Reprieve For Boston Scientific (BSX)

Tuesday’s Top Biotech and Medical Stocks

VIVUS Looking to Profit from Obesity and Sexual Dysfunction

Pfizer Draw Short Interest (PFE)(MRK)

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan